Cerner, University of Missouri extend relationship for more care innovation

After nearly two decades of collaboration, the University of Missouri (MU) and Cerner announced plans to extend their relationship through 2025.

"This extension of the MU-Cerner collaboration will help us achieve iconic status among health systems for healthcare information technology and outstanding patient care outcomes," said MU Chancellor R. Bowen Loftin. "It will benefit all Missourians and beyond as we expand medical research, speed healthcare innovations and improve population health locally, regionally and statewide. Through this collaboration, MU has been able to achieve early success in implementing healthcare technology solutions, and we are now able to move forward with new goals to improve patient care."

In 2009, the two formed the Tiger Institute for Health Innovation to deliver value through information technology and innovation. With this extension, the Tiger Institute will focus on key advancements in population health, research, cost-saving opportunities and becoming a key resource for health organizations.

New Tiger Institute initiatives include the following:

  • Redefining patient engagement through mobile healthcare
  • Developing a comprehensive population health strategy and network to better position MU Health Care to lower costs while improving the health of Missourians and their care
  • Facilitating the role of health IT in academic medical center research
  • Helping MU Health Care and other providers transition to value-based payment models
  • Developing a Tiger Institute Value Creation Office to identify cost-saving opportunities

The team will establish the Tiger Institute Leadership Academy for industry peers who are interested in on-site visits and education. Last year, the Tiger Institute hosted visitors from around the globe, including physicians and medical executives from Australia, France, China and Intermountain Healthcare.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.